BAZ1A and malignant colon neoplasm: Another unreported finding in SFN-treated human colon cancer cells was the alternative splicing of BAZ1A, extending prior observations on exon skipping/inclusion in a mouse model of prostate cancer after feeding SFN in the diet [32].